Morepen Laboratories Ltd 500288
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- INR 49.76
- Day Range
- INR 49.23–50.16
- 52-Week Range
- INR 25.34–56.35
- Bid/Ask
- INR 49.35 / INR 49.43
- Market Cap
- INR 25.27 Bil
- Volume/Avg
- 217,468 / 511,710
Key Statistics
- Price/Earnings (Normalized)
- 33.17
- Price/Sales
- 1.54
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Morepen Laboratories Ltd is an India based pharmaceutical company. It develops, manufactures and markets generic drugs and pharmaceutical formulations. The company's products includes Tablets, Capsules, Injections, Ointments, Syrups, and Powders. It also offers products under brands Burnol, Lemolate and Fiber-X. The company's geographical markets include India, the United States and the rest of the world, with a majority of revenue being generated in India.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Growth
- Total Number of Employees
- 1,649
- Website
- https://www.morepen.com
Comparables
Valuation
|
Metric
|
500288
|
524348
|
509079
|
|---|---|---|---|
Price/Earnings (Normalized) | 33.17 | 26.75 | 38.81 |
Price/Book Value | 3.22 | 3.55 | 8.30 |
Price/Sales | 1.54 | 1.80 | 4.16 |
Price/Cash Flow | 31.46 | 20.24 | 30.89 |
Price/Earnings
500288
524348
509079
Financial Strength
|
Metric
|
500288
|
524348
|
509079
|
|---|---|---|---|
Quick Ratio | 0.95 | 0.91 | 0.74 |
Current Ratio | 2.23 | 1.66 | 1.35 |
Interest Coverage | 30.56 | 8.03 | 8.37 |
Quick Ratio
500288
524348
509079
Profitability
|
Metric
|
500288
|
524348
|
509079
|
|---|---|---|---|
Return on Assets (Normalized) | — | 7.10% | — |
Return on Equity (Normalized) | — | 13.89% | — |
Return on Invested Capital (Normalized) | — | 10.74% | — |
Return on Assets
500288
524348
509079
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Thzxjywz | Gpmrkh | $78.2 Bil | |
ZTS
| Zoetis Inc Class A | Nqtwqrxk | Trtmc | $78.0 Bil | |
HLN
| Haleon PLC ADR | Ddpjhntb | Hllzn | $38.2 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Rwkrlfbj | Tclwz | $19.1 Bil | |
VTRS
| Viatris Inc | Kgzvzhtz | Ttswr | $12.5 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Swgztwnjs | Tshvj | $11.8 Bil | |
CTLT
| Catalent Inc | Ypfgzpsn | Ylmgshz | $9.9 Bil | |
PRGO
| Perrigo Co PLC | Wnkngdtz | Kzcp | $3.8 Bil | |
CURLF
| Curaleaf Holdings Inc | Wkbjxdvs | Fggp | $3.5 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Dgcdsky | Cghdnc | $3.2 Bil |